Especifique uma ação ou criptomoeda na barra de pesquisa para obter um resumo
Marksans Pharma Limited
MARKSANSMarksans Pharma Limited, together with its subsidiaries, engages in the research, manufacturing, marketing, and sale of pharmaceutical formulations in the United States, North America, Europe, the United Kingdom, Australia, New Zealand, and internationally. The company offers products in the pain management, upper respiratory, cardiovascular, central nervous system, anti-diabetic, gastrointestinal, analgesics, upper respiratory, ear care, skincare, anticancer, anti-ulcerative, anti-allergy, antiviral, dietary, cardiac, dermatology, antihistamines, anti-fungal, anti-viral, laxatives, and cold and cough therapeutic areas. It also produces a range of solid oral dosage forms, including tablets and hard gelatin capsules; soft gels; essential oils; ointments; and creams and liquids, as well as prescription drugs. The company provides its products to supermarkets, high street retailers, pharmacy chains, and wholesalers. Marksans Pharma Limited was incorporated in 1992 and is headquartered in Mumbai, India. Address: Grandeur, Mumbai, India, 400053
Analytics
Preço Alvo de Wall Street
2 617.34 INRRácio P/E
40.8144Rendimento de dividendos
0.2 %Ano atual
Ano passado
Trimestre Atual
Ultimo quarto
Ano atual
Ano passado
Trimestre Atual
Ultimo quarto
Figuras chave MARKSANS
Análise de Dividendos MARKSANS
Crescimento de dividendos em 5 anos
900 %Crescimento contínuo
1 anoTaxa de pagamento em média de 5 anos
5 %Histórico de Dividendos MARKSANS
Avaliação de ações MARKSANS
Relatório MARKSANS
Acompanhe as principais métricas de cada ação em um só lugar, sem complicações
Inscreva-se no premiumResultados | 2019 | Dinâmica |